Modul: Na izsledkih temelječa medicina. Veljko Ignjatović

Similar documents
GINKGO BILOBA IN MISELNE SPOSOBNOSTI. Avtorji: Jelena Raković, Božica Ljušanin Grbavac 18. modularna skupina April 2015

ALI SO PRIPRAVKI GLUKOZAMINA UČINKOVITI V TERAPIJI GONARTROZE?

Maastricht Ⅴ /Florence

Obravnava otrok, okuženih z bakterijo

Sašo Duh, Mojca Prica, Manja Vivod NA DOKAZIH TEMELJEČA MEDICINA MODULARNA NALOGA

Uvodnik / Editoral. Lojze Šmid GASTROENTEROLOG 1

ALI JE DOLGOTRAJNA UPORABA ZAVIRALCEV PROTONSKE ČRPALKE VARNA?

Domača naloga 21. modularna skupina

MODUL: NA DOKAZIH TEMELJEČA MEDICINA. ZD SLOV.KONJICE Lucija Kračun, dr.med Loče,

Esophageal Adenocarcinoma Developing after Eradication of Helicobacter pylori

Antikoagulantno zdravljenje

Helicobacter Pylori: Treatment Rates and Strategies for Improvement in a Community Health Center Population

HelicobacterPyloriandStepsforitsEliminationAReview

A Heaney, J S A Collins, RGPWatson, R J McFarland, K B Bamford, T C K Tham

C-urea breath test in Helicobacter pylori positive and negative dyspepsia patients on proton pump inhibitors

Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates

Influence of proton pump inhibitor treatment on Helicobacter pylori stool antigen test

HIV/AIDS UPDATE Janez Tomažič Klinika za infekcijske bolezni in vročinska stanja Katedra za infekcijske bolezni in epidemiologijo

Clinical Policy: Helicobacter Pylori Serology Testing Reference Number: CP.MP.153

Malaysian Journal of Microbiology

Helicobacter pylori: Diagnosis, treatment and risks of untreated infection

Treating Helicobacter pylori effectively while minimizing misuse of antibiotics

What is the status of Sequential Therapy Versus Standard Triple- Drug Therapy in peptic ulcer disease in eradicating H pylori?

Title: A real life study of Helicobacter pylori eradication with bismuth quadruple therapy in naïve and previously treated patients

Ten-day quadruple therapy comprising low-dose rabeprazole, bismuth, amoxicillin and tetracycline is an effective and safe

Perspectives from Viet Nam

Comparison of the Accuracy of Two Commercial Rapid Urase Tests, CLOtest and Pronto Dry, in Detecting Helicobacter pylori Infection ABSTRACT

Efficacy of Proton Pump Inhibitor-based Triple Therapy and Bismuth-based Quadruple Therapy for Helicobacter pylori Eradication in Korean Children

Uvodnik. Prof. dr. Borut Štabuc, dr. med., urednik GASTROENTEROLOG 1

Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication

Effect of Helicobacter pylori Eradication on Reflux Esophagitis Therapy: A Multi center Randomized Control Study

Sitafloxacin activity against Helicobacter pylori including isolates with gyra. Key words: Helicobacter pylori, sitafloxacin, antimicrobial activity,

Use of a combination formulation of bismuth, metronidazole and tetracycline with omeprazole as a rescue therapy for eradication of Helicobacter pylori

Helicobacter pylori Improved Detection of Helicobacter pylori

COMPARISON OF ONCE-A-DAY VERSUS TWICE-A-DAY CLARITHROMYCIN IN TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION

Is there a role for screening gastric carcinoma or preneoplastic lesions?

A Pilot Study of Helicobacter pylori Eradication Using a Polymerase Chain Reaction-based Test for Clarithromycin Resistance

RESEARCH ARTICLE. Abstract. Introduction

Research Article Performance of Routine Helicobacter pylori Invasive Tests in Patients with Dyspepsia

Additional corpus biopsy enhances the detection of Helicobacter pylori infection in a background of gastritis with atrophy

Mutacijska analiza v genu ABL1

Extremely high prevalence of Helicobacter pylori infection in Bhutan

Investigating dyspepsia Rocco Maurizio Zagari, Lorenzo Fuccio, Franco Bazzoli

Efficacy and Tolerability of a Third-Line, Levofloxacin-Based, 10-Day Sequential Therapy in Curing Resistant Helicobacter Pylori Infection

Usmerjeno zdravljenje okužbe z bakterijo Helicobacter pylori ali še obstaja druga pot? Sistematični pregled literature in metaanaliza

The gastroenterologist and chronic gastritis in daily clinical practice

SYNBIOTIC THERAPY INCREASES ERADICATION RATE IN HELICOBACTER PYLORI ERADICA- TION

Original article J Bas Res Med Sci 2015; 2(4):45-50.

Effectiveness of ranitidine bismuth citrate and proton pump inhibitor based triple therapies of Helicobacter pylori in Turkey

Helicobacter pylori Eradication Therapy Success Regarding Different Treatment Period Based on Clarithromycin or Metronidazole Triple-Therapy Regimens

Evaluation of a new rapid immunoassay for the detection of Helicobacter pylori in faeces: a prospective pilot study

Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies

Is the prescription of azithromycin instead of clarithromycin more effective in the sequential therapy of helicobacter pylori eradication?

Treatment for H. pylori Infection. New Challenges With Antimicrobial Resistance

Quadruple therapy for eradication of Helicobacter pylori

Obravnava bolnika z akutno okužbo sečil v ambulanti zdravnika družinske medicine

Management of H. pylori Resistance

Helicobacter pylori Eradication within 120 Days Is Associated with Decreased Complicated Recurrent Peptic Ulcers in Peptic Ulcer Bleeding Patients

Etiology of duodenal ulcers in a Colombian population

Prevalence of helicobacter pylori among Nigerian patients with dyspepsia in Ibadan

Zdravljenje pridobljene hemofilije. Irena Preložnik Zupan

MEDICAL POLICY EFFECTIVE DATE: 05/19/11 REVISED DATE: 05/24/12, 05/23/13 ARCHIVED DATE: 05/22/14 EDITED DATE: 05/28/15, 05/25/16, 05/18/17, 05/17/18

The Association and Clinical Implications of Gastroesophgeal Reflux Disease and H. pylori

Seven-day quintuple regimen as a rescue therapy for Helicobacter pylori eradication

HpSA fecoprevalence in patients suspected to have Helicobacter pylori infection in Istanbul, Turkey

Efficacy of the Kyoto Classification of Gastritis in Identifying Patients at High Risk for Gastric Cancer

Chung-Chuan Chan 1,5, Nai-Hsuan Chien 3,4, Chia-Long Lee 3,5*, Yi-Chen Yang 2, Chih-Sheng Hung 3, Tien-Chien Tu 3,5 and Chi-Hwa Wu 3

Optimised empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON study

A systematic review and meta-analysis of the role of Helicobacter pylori eradication in preventing gastric cancer

Mitigating GI Risks Associated with the Use of NSAIDs

High Recurrence Rate of Idiopathic Peptic Ulcers in Long-Term Follow-up

instrument. When 13C-UBT positive value is greater than or equal to / - 0.4, the the subject can be 1. Data and methods details are as follows:

Priporočila za zdravljenje primarne imunske trombocitopenije. Barbara Skopec

Moradniani et al., IJPSR, 2017; Vol. 8(8): E-ISSN: ; P-ISSN:

The diagnosis and management of H. pylori infection in Singapore

Clinical Study Is There Any Advantage of Treating Partners in Helicobacter pylori Eradication?

Comparison of 7-day triple, 10-day sequential and 7-day concomitant therapies. for Helicobacter pylori infection a randomized controlled trial

Efficacy of standard triple therapy versus bismuth-based quadruple therapy for eradication of Helicobacter Pylori infection

Helicobacter pylori Infection

Antibiotic resistance of Helicobacter pylori from patients in Ile-Ife, South-west, Nigeria

Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori

Sladkorna bolezen in kirurški poseg

Comparison of sequential therapy for eradication of Helicobacter pylori with standard triple therapy

1PODhRANJENOST PRI KLINIČNA PREHRANA IN KRONIČNA VNETNA ČREVESNA BOLEZEN CLINICAL NUTRITION AND INFLAMMATORY BOWEL DISEASE

Predstavitev smernic za osteoporozo

Principi PET-CT preiskave. Marko Grmek

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Helicobacter pylori CHAPTER 51: Author V.Y. Miendje Deyi, PharmD, PhD

Modulo 8: Laboratory diagnosis of Helicobacter pylori infection

R J M E Romanian Journal of Morphology & Embryology

Non-invasive techniques for the diagnosis of Helicobacter pylori infection

UNIVERZA V LJUBLJANI FAKULTETA ZA FARMACIJO

(Index words: Clarithromycin, compliance, efficacy, tinidazole and omeprazole therapy)

Beyond Maastricht IV: are standard empiric triple therapies for Helicobacter pylori still useful in a South-European country?

Diagnosis of Helicobacter Pylori Infection is Associated with Lower Prevalence and Subsequent Incidence of Crohn s Disease

Clinical Study Comparison of Second-Line Quadruple Therapies with or without Bismuth for Helicobacter pylori Infection

ORIGINAL INVESTIGATION. One-Day Quadruple Therapy Compared With 7-Day Triple Therapy for Helicobacter pylori Infection

The association of and -related gastroduodenal diseases

Helicobacter pylori resistance in the Netherlands: a growing problem?

Received 17 August 2010/Returned for modification 7 December 2010/Accepted 16 December 2010

Transcription:

Modul: Na izsledkih temelječa medicina Veljko Ignjatović

Opis problema: Ambulanto družinske medicine, večkrat na leto obišče gospa srednjih let, po poklicu uslužbenka v banki, zaradi suhega kašlja, hripavosti in občutka pekoče bolečine v zgornjem delu trebuha. Težave so najbolj izrazite po noči. Gastroskopski je ugotovljeno kronično vnetje sluznice želodca, patohistološki pa je potrjeno prisotnost bakterije Helicobacter pylori. Po nasvetu gastroenterologa je bila indicirana trotirna eradikacijska terapija: Zaviralec protonske črpalke 2x40mg + Amoksicilin 2x1000mg + Klaritromicin 2x500mg 7 dni. Po končani predpisani terapiji je bil narejen kontrolni ureaza dihalni test ki je pokazal da je določena kombinacija zdravil ni bila unčikovita.

Vprašanje: 1. Ali je smisleno ponovno poskusiti z enakom kombinacijom zdravil in kako dolgo naj bi zdravljenje trajalo? 2. Katera bi bila alternativna terapija v primeru rezistence? Relevantnost problema za delo v ambulanti: Kronični gastritis je široko razširjena bolezen gastrointestinalnega trakta Vzročnik najpogostejše oblike je bakterija Helicobacter pylori

10-20% okuženih razvije ulkusno bolezen želodca ali dvanajsternika okužba odgovorna za vsaj 71% do 95% vsih rakov želodca Kronično vnetje gastrične sluznice provzročeno z bakterijo H. Pylori vodi v nastanek multifokalnega atrofičnega gastritisa in intestinalne metaplazije, histoloških sprememb ki veljajo za predhodne spremembe intestinalnega tipa adenokarcinoma želodca in MALT limfoma. SZO zato uvršča bakterijo H. pylori med karcinogene prvega razreda.

Pregled relevantnih člankov in virov 1. Tepeš B. Helicobacter pylori diagnostika, zdravljenje in rezistenca na antibiotike v Sloveniji. Revija slovenskega združenja za gastroenterologijo in hepatologijo - Gastroenterolog, Letnik 17, suplement 2, junij 2013 2. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007 Jun;56(6):772-81. Epub 2006 Dec 14. PMID: 17170018 [PubMed - indexed for MEDLINE] 3. Yang JC, Lu CW, Lin CJ. Treatment of Helicobacter pylori infection: current status and future concepts. World J Gastroenterol. 2014 May 14;20(18):5283-93. doi: 10.3748/wjg.v20.i18.5283. PMID: 24833858 [PubMed - in process] 4. Graham DY, Shiotani A. New concepts of resistance in the treatment of Helicobacter pylori infections.nat Clin Pract Gastroenterol Hepatol. 2008 Jun;5(6):321-31. doi: 10.1038/ncpgasthep1138. Epub 2008 Apr 29. Review.PMID:18446147[PubMed - indexed for MEDLINE] 5. Tepes B., O' Connor A., Gisbert J.P., O' Morain C., Treatment of Helicobacter pylori infection 2012. Helicobacter September 2012, Volume 17, Supplement 1, ISSN 1083-4389

Povzetek virov in osnovnih dilem Po priporočilih Slovenskega združenja za gastrologijo in hepatologijo (SZGH) se okužba s Helicobacter pylori zdravi z zaviralcem protonske črpalke, amoksicilinom/ metronidazolom in klaritromicinom dvakrat dnevno, v trajanju 7 dni. predlagana trotirna shema (ZPČ- klaritromicin - amoksicilin, 2xdnevno, 7 dni, ZAK) z izjemo, da bi se pri bolnikih, ki so bili v življenju večkat zdravljeni z makrolidi, klaritromicin zamenjal z metronidazolom, ZAM. Uspeh klasičnega trotirnega zdravljenja je mogoče izboljšati: Zvišanjem ZPČ 2x40mg in se uspeh izboljša za 6% do 10% Podaljšanje trajanja zdravljenja na 10 dni izboljša uspeh zdravljenja za 4%, podaljšanje na 14 dni pa za 5-6%.

Kot terapijo tretjaga izbora ali rescue therapy se svetuje desetodnevno zdravljenje z ZPČ+Amoksicilin+Levofloksacin ali pa zdravljenje po antibiogramu. Zdravljenje druge izbire mora biti desetdnevno. V primeru neuspeha zdravljenja naslednje priporočeno zdravljenje je desetodnevno zdravljenje z ZPČ +Amoksicilinom+Metronidazol+Klaritromicin dvakrat dnevno. Kot terapijo tretjaga izbora ali rescue therapy se svetuje desetodnevno zdravljenje z ZPČ+Amoksicilin+Levofloksacin ali pa zdravljenje po antibiogramu.

Priporočilo za prakso na osnovi dokazov in stanja v ambulanti Zdravnik družinske medicine začne zdravljenje z zaviralcem protonske črpalke, amoksicilinom in klaritromicinom dvakrat dnevno, v trajanju 7 dni. Čez mesec dni, če je urea dihalni test ali določanje monoklonalnih protiteles proti Helicobacter pylori v blatu pozitivno, terapija se podaljša na 10 dni z ZPČ, amoksicilinom in metronidazolom dvakrat dnevno. Če je kontrolni test spet pozitiven je smisleno narediti kontrolno gastroskopijo in na podlagi kulture ordinirati antibiotsko terapijo